[ ZipLine Medical raises $12M in Series E funding ]
ZipLine Medical has raised $12 million in Series E funding.
Founded in 2007, ZipLine Medical develops and markets tissue repair devices to address the clinical need for rapid, non-invasive and easy-to-use skin closure.
Proceeds from the financing will be used to continue worldwide commercialization activities for its Zip® Surgical Skin Closure products, as well as development of advanced tools to reduce post-discharge costs in a bundled care environment.
|Founder / CEO||John R. Tighe|
|Investors||MVM Life Science Partners|
|Previous Investors||China Materialia|
|Claremont Creek Ventures|
|RA Capital Management|
|MVM Life Science Partners|